2019
Viralgen will open the first drug manufacturing plant of gene therapy in Spain
24/10/2019This infrastructure will involve an investment of more than 50 million euros and will be one of the most advanced in... Read More
Aura Biosciences Announces Clinical Data at AAO 2019 Annual Meeting
02/10/2019Aura Biosciences Announces Clinical Data Presentations at the Upcoming American Academy of Ophthalmology 2019 Annual Meeting CAMBRIDGE, Mass.-- Aura Biosciences,... Read More
Viralgen Receives cGMP Certification from European Medicines Agency
27/08/2019Viralgen Receives cGMP Certification from European Medicines Agency Certification confirms Viralgen’s commitment to high operational standards with the world’s most... Read More
Selecta Biosciences partners with AskBio to lead the next generation of gene therapy treatments
08/08/2019Selecta Biosciences CombinesImmTOR™ Platform with AskBio’s Industry-Leading Gene Therapy Platformin Strategic Partnership Selecta Biosciences, Inc.(NASDAQ: SELB) and Asklepios BioPharmaceutical, Inc.... Read More
Caixa Capital Risc
27/06/2019Caixa Capital Risc Caixa Capital Risc leads the largest operation in the history of the biotechnology sector in Spain https://www.abc.es/economia/abci-criteriacaixa-capital-lidera-mayor-operacion-historia-sector-biotecnologico-espana-201906260918_noticia.html Read More
AskBio Partners with TPG and Vida Ventures
12/04/2019AskBio Partners with TPG and Vida Ventures Leading gene therapy company announces $235 million investment to accelerate growth https://www.businesswire.com/news/home/20190411005352/en/AskBio-Partners-TPG-Vida-Ventures Read More
Aura Biosciences Completes $40 Million Series D Financing
02/04/2019Aura announces the $40 million Series D round April 02, 2019.CAMBRIDGE, Mass.-Aura Biosciences, a leader in the development of novel targeted... Read More
Pfizer secures exclusive option to acquire Vivet Therapeutics
20/03/2019Pfizer acquires 15% ownership stake in Vivet Paris, France and New York, US, March 20, 2019 – Vivet Therapeutics (“Vivet”),... Read More
PTS opens the first plant in Europe to manufacture polipeptides
20/03/2019Industrial scale of nanomedicine….
Read MoreColumbus register at the CNMV its second Fund , Columbus Life Science Fund II
04/02/2019Columbus Life Science Fund II will complete the first closing by end of February with a target of €70M MADRID... Read More